CERE (Cerevel Therapeutics) Volume dana dhuwit perusahaan

Logo grafis Cerevel Therapeutics (CERE)

Patent protection for the neural developments of Cerevel Therapeutics (CERE) minimizes financial risks, and current cash reserves on GURU.Markets demonstrate this resilience, where the value 0.84 denotes the current metric. Capital is sustained by attracting elite scientists through RSUs, and a strategic acquisition by a pharma behemoth has definitively confirmed its status as a reliable industry leader, optimizing the company's overall resource value.

Total volume dana dhuwit perusahaan: Cerevel Therapeutics Inc (CERE) kanggo 04.07.2022 - 10.08.2024

Rincian analitis perusahaan Cerevel Therapeutics

- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Ringkesan analisis perusahaan:cerevel.com
Sampel barang Cerevel Therapeutics Inc

Operating cash flow dynamics reflect the financial stability of Cerevel Therapeutics (CERE) within the neurology sector. This indicator captures the gap between incoming cash flows and the organization's current expenditures. The calculation is based on daily balance monitoring, which allows for the real-time identification of hidden capital burn. For biopharmaceuticals, this is critical when financing eco-friendly laboratory filtration systems. A stable liquidity balance guarantees investors the uninterrupted development of innovative drugs.

Pesaing utama

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|ATXI - Cadangan dhuwit perusahaan|Volume dana dhuwit perusahaan BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Cadangan dhuwit perusahaan|CHRO: Dhuwit awis perusahaan|Eliem Therapeutics Inc. (ELYM) - Dhuwit awis perusahaan|Intra-Cellular Therapies Inc. (ITCI) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan LBPH (Longboard Pharmaceuticals)|MRNS (marinuspharma.com) - Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan NKGN (NKGen Biotech Inc)|Volume dana dhuwit perusahaan NRBO|Dhuwit awis perusahaan Sage Therapeutics Inc SAGE|Dana dhuwit perusahaan Synaptogenix SNPX|TRVN: Dhuwit awis lan setara dhuwit awis perusahaan|VIGL - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anew Medical